Track topics on Twitter Track topics that are important to you
We list hundreds of Clinical Trials about "Neuer Vorstand Verbund holt sich Verst rkung Cisco" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.
We have published hundreds of Neuer Vorstand Verbund holt sich Verst rkung Cisco news stories on BioPortfolio along with dozens of Neuer Vorstand Verbund holt sich Verst rkung Cisco Clinical Trials and PubMed Articles about Neuer Vorstand Verbund holt sich Verst rkung Cisco for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neuer Vorstand Verbund holt sich Verst rkung Cisco Companies in our database. You can also find out about relevant Neuer Vorstand Verbund holt sich Verst rkung Cisco Drugs and Medications on this site too.
Background: Intravenous thrombolysis (IVT) combined with mechanical thrombectomy (MT) has been proven safe and effective in patients with acute ischemic stroke (AIS) of anterior circulation large vessel occlusion (LVO). Despite recanalization, a considerable proportion of patients do not recover. The incidence of symptomatic intracerebral hemorrhage (sICH) was similar between bridging therapy and IVT, suggesting that this complication could not be attributed to the MT, but rath...
The purpose of this study is to confirm the efficacy and safety of intravenously administered alteplase in patients with acute ischemic stroke based on the rate of recanalization assessed by magnetic resonance angiography (MRA), the rate of patients with a modified Rankin Scale (mRS) score of 0-1, and the incidence of symptomatic intracranial hemorrhage (sICH), in comparison with the data reported in the current literature.